TRBV20OR9-2 and myeloid sarcoma: To better understand the potential mechanism of B cells in MS pathology, Baranzini et al. had PCR amplified and analyzed by size, spectratyping, and sequencing the Ig heavy chain CDR3 repertoire in 10 MS brain samples.